1.22BMarket Cap
40.68P/E TTM
Financial Health
Currency: USD Updated: 2026-06-18 The current financial score of Alvotech SA is 6.82, ranking 203 out of 389 in the Biotechnology & Medical Research industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 105.94M, representing a year-over-year decrease of 20.23%, while its net profit experienced a year-over-year decrease of 99.06%.
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow

Relevant data have not been disclosed by the company yet.
Total revenue
Operating profit
Total assets
SG&A

Relevant data have not been disclosed by the company yet.
Cash flow from operating activities
Income after tax

Relevant data have not been disclosed by the company yet.
Cash flow from operating activities
Total revenue

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.